Key result
Initial PAH therapy yielded a higher response rate in patients with severe pulmonary hypertension and mild ventilatory impairment compared to all other groups.
Why the study?
Does initial PAH therapy improve outcomes in patients with pulmonary hypertension associated with lung disease?
Does initial PAH therapy improve outcomes in patients with pulmonary hypertension associated with lung disease?
Answers are grounded in this paper and cite their sources.
This editorial highlights that patients with severe pulmonary hypertension and mild ventilatory impairment associated with lung disease may benefit most from early initiation of PAH therapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2024) conducted an editorial in Pulmonary hypertension associated with interstitial pneumonia or combined pulmonary fibrosis and emphysema (CPFE) (n=270). Initial PAH treatment vs. Noninitial treatment was evaluated on Response rate (improved World Health Organization functional class, PVR decrease >15%, or 6-minute walk distance increase >15% at first follow-up). Initial PAH therapy yielded a higher response rate in patients with severe pulmonary hypertension and mild ventilatory impairment compared to all other groups.
Synapse has enriched 10 related papers. Consider them for comparative context: